BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS

The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which bind to natural killer (NK) cells. The invention also inc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BRANDISH, Phil, DUFORT, Fay, UHLENBROICH, Sandra, MCDONNELL, Kevin, REPASH, Liz, KEEN, Nicholas, GAYNOR, Katie, CHEN, Liuhong, MUDD, Gemma, LEITHEISER, Chris
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BRANDISH, Phil
DUFORT, Fay
UHLENBROICH, Sandra
MCDONNELL, Kevin
REPASH, Liz
KEEN, Nicholas
GAYNOR, Katie
CHEN, Liuhong
MUDD, Gemma
LEITHEISER, Chris
description The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which bind to natural killer (NK) cells. The invention also includes multimeric binding complexes comprising at least two of said bicyclic peptide ligands. The invention also includes pharmaceutical compositions comprising said peptide ligands or said multimeric binding complexes and the use of said peptide ligands, multimeric binding complexes and pharmaceutical compositions in preventing, suppressing or treating a disease or disorder mediated by natural killer (NK) cells, such as inflammatory disorders, autoimmune disease and cancer.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2022206394A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2022206394A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2022206394A13</originalsourceid><addsrcrecordid>eNrjZNBz8nSOdPbxdFYIcA0I8XRxVfDxdHf0cwlWCA5wdfZ0A0q4-Qcp-HkrOLv6-ATzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JJ4x1AjAyMjIwMzY0sTR0Nj4lQBAE5XJik</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS</title><source>esp@cenet</source><creator>BRANDISH, Phil ; DUFORT, Fay ; UHLENBROICH, Sandra ; MCDONNELL, Kevin ; REPASH, Liz ; KEEN, Nicholas ; GAYNOR, Katie ; CHEN, Liuhong ; MUDD, Gemma ; LEITHEISER, Chris</creator><creatorcontrib>BRANDISH, Phil ; DUFORT, Fay ; UHLENBROICH, Sandra ; MCDONNELL, Kevin ; REPASH, Liz ; KEEN, Nicholas ; GAYNOR, Katie ; CHEN, Liuhong ; MUDD, Gemma ; LEITHEISER, Chris</creatorcontrib><description>The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which bind to natural killer (NK) cells. The invention also includes multimeric binding complexes comprising at least two of said bicyclic peptide ligands. The invention also includes pharmaceutical compositions comprising said peptide ligands or said multimeric binding complexes and the use of said peptide ligands, multimeric binding complexes and pharmaceutical compositions in preventing, suppressing or treating a disease or disorder mediated by natural killer (NK) cells, such as inflammatory disorders, autoimmune disease and cancer.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230824&amp;DB=EPODOC&amp;CC=AU&amp;NR=2022206394A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230824&amp;DB=EPODOC&amp;CC=AU&amp;NR=2022206394A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BRANDISH, Phil</creatorcontrib><creatorcontrib>DUFORT, Fay</creatorcontrib><creatorcontrib>UHLENBROICH, Sandra</creatorcontrib><creatorcontrib>MCDONNELL, Kevin</creatorcontrib><creatorcontrib>REPASH, Liz</creatorcontrib><creatorcontrib>KEEN, Nicholas</creatorcontrib><creatorcontrib>GAYNOR, Katie</creatorcontrib><creatorcontrib>CHEN, Liuhong</creatorcontrib><creatorcontrib>MUDD, Gemma</creatorcontrib><creatorcontrib>LEITHEISER, Chris</creatorcontrib><title>BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS</title><description>The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which bind to natural killer (NK) cells. The invention also includes multimeric binding complexes comprising at least two of said bicyclic peptide ligands. The invention also includes pharmaceutical compositions comprising said peptide ligands or said multimeric binding complexes and the use of said peptide ligands, multimeric binding complexes and pharmaceutical compositions in preventing, suppressing or treating a disease or disorder mediated by natural killer (NK) cells, such as inflammatory disorders, autoimmune disease and cancer.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBz8nSOdPbxdFYIcA0I8XRxVfDxdHf0cwlWCA5wdfZ0A0q4-Qcp-HkrOLv6-ATzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JJ4x1AjAyMjIwMzY0sTR0Nj4lQBAE5XJik</recordid><startdate>20230824</startdate><enddate>20230824</enddate><creator>BRANDISH, Phil</creator><creator>DUFORT, Fay</creator><creator>UHLENBROICH, Sandra</creator><creator>MCDONNELL, Kevin</creator><creator>REPASH, Liz</creator><creator>KEEN, Nicholas</creator><creator>GAYNOR, Katie</creator><creator>CHEN, Liuhong</creator><creator>MUDD, Gemma</creator><creator>LEITHEISER, Chris</creator><scope>EVB</scope></search><sort><creationdate>20230824</creationdate><title>BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS</title><author>BRANDISH, Phil ; DUFORT, Fay ; UHLENBROICH, Sandra ; MCDONNELL, Kevin ; REPASH, Liz ; KEEN, Nicholas ; GAYNOR, Katie ; CHEN, Liuhong ; MUDD, Gemma ; LEITHEISER, Chris</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2022206394A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BRANDISH, Phil</creatorcontrib><creatorcontrib>DUFORT, Fay</creatorcontrib><creatorcontrib>UHLENBROICH, Sandra</creatorcontrib><creatorcontrib>MCDONNELL, Kevin</creatorcontrib><creatorcontrib>REPASH, Liz</creatorcontrib><creatorcontrib>KEEN, Nicholas</creatorcontrib><creatorcontrib>GAYNOR, Katie</creatorcontrib><creatorcontrib>CHEN, Liuhong</creatorcontrib><creatorcontrib>MUDD, Gemma</creatorcontrib><creatorcontrib>LEITHEISER, Chris</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BRANDISH, Phil</au><au>DUFORT, Fay</au><au>UHLENBROICH, Sandra</au><au>MCDONNELL, Kevin</au><au>REPASH, Liz</au><au>KEEN, Nicholas</au><au>GAYNOR, Katie</au><au>CHEN, Liuhong</au><au>MUDD, Gemma</au><au>LEITHEISER, Chris</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS</title><date>2023-08-24</date><risdate>2023</risdate><abstract>The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which bind to natural killer (NK) cells. The invention also includes multimeric binding complexes comprising at least two of said bicyclic peptide ligands. The invention also includes pharmaceutical compositions comprising said peptide ligands or said multimeric binding complexes and the use of said peptide ligands, multimeric binding complexes and pharmaceutical compositions in preventing, suppressing or treating a disease or disorder mediated by natural killer (NK) cells, such as inflammatory disorders, autoimmune disease and cancer.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2022206394A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T15%3A02%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BRANDISH,%20Phil&rft.date=2023-08-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2022206394A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true